EAM
PTLA

Eagle Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Eagle Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-482,719
Closed -$11.4M – 672
2016
Q2 		$11.4M Sell
482,719
-218,228
-31% -$5.39M 0.08% 306
2016
Q1 		$14.3M Sell
700,947
-521,533
-43% -$16.5M 0.1% 275
2015
Q4 		$62.9M Sell
1,222,480
-12,123
-1% -$588K 0.42% 76
2015
Q3 		$52.6M Sell
1,234,603
-236,565
-16% -$11.4M 0.36% 86
2015
Q2 		$67M Buy
1,471,168
+5,368
+0.4% +$216K 0.38% 95
2015
Q1 		$55.6M Sell
1,465,800
-162,113
-10% -$5.57M 0.32% 112
2014
Q4 		$46.1M Sell
1,627,913
-101,545
-6% -$2.82M 0.27% 133
2014
Q3 		$43.7M Buy
1,729,458
+110,937
+7% +$2.92M 0.25% 143
2014
Q2 		$47.2M Buy
1,618,521
+467,107
+41% +$11.3M 0.26% 134
2014
Q1 		$29.8M Buy
+1,151,414
New +$30.7M 0.16% 190

Other funds holding PTLA

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Eagle Asset Management's PTLA Position: Q3 2016 in Review

Eagle Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2016, closing a stake of 482,719 shares — an estimated $11.4M sold.

Eagle Asset Management first reported a position in PTLA in Q1 2014 and held it in 10 quarters. The position peaked at $67M in Q2 2015. 151 funds tracked by Wall St. Rank hold PTLA as of Q3 2016.

  • Eagle Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Eagle Asset Management sold 482,719 Portola Pharmaceuticals, Inc. shares in Q3 2016, an estimated $11.4M.
  • Eagle Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q1 2014 and held it in 10 quarters.
  • Eagle Asset Management's Portola Pharmaceuticals, Inc. position peaked at $67M in Q2 2015.
  • 151 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2016.

Based on Eagle Asset Management's 13F filing for Q3 2016, filed 12 Oct 2016.